LSERS
PGNX

Louisiana State Employees Retirement System’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-23,850
Closed -$91K – 1355
2020
Q1 		$91K Sell
23,850
-5,730
-19% -$24.7K 0.01% 1226
2019
Q4 		$151K Sell
29,580
-2,320
-7% -$12.3K 0.01% 1392
2019
Q3 		$161K Buy
31,900
+300
+0.9% +$1.5K 0.01% 1377
2019
Q2 		$178K Hold
31,600
– – 0.01% 1387
2019
Q1 		$147K Sell
31,600
-135
-0.4% -$611 0.01% 1411
2018
Q4 		$133K Sell
31,735
-5,265
-14% -$26.8K 0.01% 1391
2018
Q3 		$232K Buy
37,000
+4,000
+12% +$30.7K 0.01% 1418
2018
Q2 		$265K Buy
33,000
+1,800
+6% +$13.7K 0.01% 1400
2018
Q1 		$233K Buy
31,200
+1,000
+3% +$6.65K 0.01% 1394
2017
Q4 		$180K Buy
30,200
+1,700
+6% +$10.3K 0.01% 1433
2017
Q3 		$210K Sell
28,500
-100
-0.3% -$635 0.01% 1393
2017
Q2 		$194K Buy
28,600
+100
+0.4% +$738 0.01% 1399
2017
Q1 		$269K Buy
+28,500
New +$284K 0.01% 1322

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Louisiana State Employees Retirement System's PGNX Position: Q2 2020 in Review

Louisiana State Employees Retirement System sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 23,850 shares — an estimated $91K sold.

Louisiana State Employees Retirement System first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $269K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Louisiana State Employees Retirement System reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 23,850 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $91K.
  • Louisiana State Employees Retirement System first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
  • Louisiana State Employees Retirement System's Progenics Pharmaceuticals Inc position peaked at $269K in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2020, filed 13 Jul 2020.